Physician profile
Kenneth B Lee
NPI 1366678864
$513.54
in general payments reported to CMS, 2019-2025
9 companies · $62.06 in 2025
The $62.06 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.83 · 2021: $43.84 · 2022: $74.09 · 2023: $170 · 2024: $143 · 2025: $62.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $112.86 | 2022-2025 | Zerbaxa, Dificid, Recarbrio |
| Shionogi INC | $104.52 | 2023-2025 | Fetroja |
| Novartis Pharmaceuticals Corporation | $64.67 | 2019-2021 | |
| Melinta Therapeutics, LLC | $60.01 | 2022-2024 | Orbactiv, Kimyrsa, Rezzayo |
| La Jolla Pharmaceutical Company | $59.10 | 2023-2024 | Xerava |
| Pfizer INC. | $46.97 | 2022-2025 | |
| Davol INC. | $24.17 | 2024 | Phasix Mesh |
| Abbvie INC. | $21.32 | 2023 | |
| Reprise Biomedical, INC. | $19.92 | 2023 | Miro3d, Miroderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.